Industry

Interview
Martina Efeyini
Sept. 16, 2022
Anand Balakrishnan is a biochemist at Enanta Pharmaceuticals. He leads a team that has worked on respiratory syncytial virus, SARS-CoV-2 and hepatitis B virus.
Read More

More in Industry

Starting a career in data science
Jobs

Starting a career in data science

June 7, 2022

Meet Tara Baris of HUB Ocean.

Novavax is angling to win over mRNA defectors
News

Novavax is angling to win over mRNA defectors

June 4, 2022

After years of failure, the Maryland company aims to attract the vaccine-hesitant with an alternative to mRNA shots. But will it find a market?

‘We're all a bunch of weirdos doing our stuff’
Jobs

‘We're all a bunch of weirdos doing our stuff’

May 20, 2022

An interview with Charles Sanders, a research associate at XBiotech.

How Robert Langer failed repeatedly but kept going
Interview

How Robert Langer failed repeatedly but kept going

May 3, 2022

"They said I should give up, but I don’t like to give up," the pioneer in delivering mRNA to the body said.

'Anywhere you go, be ready to review your work'
Interview

'Anywhere you go, be ready to review your work'

April 29, 2022

Maria Grandoni is a scientist at PPD. She talked to our industry careers columnist about her work on the manufacturing and quality side of industry.

Ole Miss strikes $5M deal with company warned for claiming essential oils can cure COVID
News

Ole Miss strikes $5M deal with company warned for claiming essential oils can cure COVID

April 26, 2022

Companies have long sought to partner on research with public universities, which, starved for state funding, eagerly take private dollars.

Essay

Turning points

Eight scientists from academia and industry reflect on how mentors have impacted their lives.
Turning points

More in Industry

‘Have faith in that training’
Interview

‘Have faith in that training’

March 18, 2022

Raghuvir Sengupta has been a biochemist for HP and is now a Pfizer postdoc. He talks about his work and how his graduate training prepared him for his industry career.

90% of drugs fail clinical trials
Editorial

90% of drugs fail clinical trials

March 12, 2022

Here’s one way researchers can select better drug candidates.

 Inside the tactical tug of war over the controversial Alzheimer’s drug
Feature

Inside the tactical tug of war over the controversial Alzheimer’s drug

March 5, 2022

The drug, Aduhelm, with a listed price tag of $28,200 a year, has had few takers in the medical world.

'A different career almost every three years'
Interview

'A different career almost every three years'

Feb. 25, 2022

Christian Cunningham traces his path from washing dishes at Berkeley to discovering drugs at Genentech.

Society news briefs: February 2022
Society News

Society news briefs: February 2022

Feb. 14, 2022

Find out everything that’s been going on at the American Society for Biochemistry and Molecular Biology.

‘A holistic view’
Interview

‘A holistic view’

Feb. 4, 2022

As a metabolomics application specialist, Heino Heyman gets to talk metabolomics all day, helping customers plan and analyze their studies.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.